| Publication | Date of Publication | Type |
|---|
| Robust adaptive incorporation of historical control data in a randomized trial of external cooling to treat septic shock | 2024-02-20 | Paper |
| Bayesian group sequential enrichment designs based on adaptive regression of response and survival time on baseline biomarkers | 2023-10-30 | Paper |
| Bayesian hierarchical random-effects meta-analysis and design of phase I clinical trials | 2022-10-10 | Paper |
| A phase I-II basket trial design to optimize dose-schedule regimes based on delayed outcomes | 2021-12-06 | Paper |
| BAGS: A Bayesian Adaptive Group Sequential Trial Design With Subgroup-Specific Survival Comparisons | 2021-03-30 | Paper |
| An adaptive trial design to optimize dose‐schedule regimes with delayed outcomes | 2020-10-26 | Paper |
| Statistical Remedies for Medical Researchers | 2020-04-22 | Paper |
| A hybrid phase I‐II/III clinical trial design allowing dose re‐optimization in phase III | 2020-02-07 | Paper |
| Rejoinder to “A hybrid phase I‐II/III clinical trial design allowing dose reoptimization in phase III” | 2020-02-07 | Paper |
| Bayesian semiparametric joint regression analysis of recurrent adverse events and survival in esophageal cancer patients | 2019-05-22 | Paper |
| A utility‐based design for randomized comparative trials with ordinal outcomes and prognostic subgroups | 2019-03-13 | Paper |
| Clinical trial design as a decision problem | 2019-02-08 | Paper |
| A Bayesian Machine Learning Approach for Optimizing Dynamic Treatment Regimes | 2018-12-04 | Paper |
| Bayesian variable selection for a semi-competing risks model with three hazard functions | 2018-08-07 | Paper |
| https://portal.mardi4nfdi.de/entity/Q4642533 | 2018-05-23 | Paper |
| A decision-theoretic comparison of treatments to resolve air leaks after lung surgery based on nonparametric modeling | 2018-02-23 | Paper |
| Bayesian Dose-Finding in Two Treatment Cycles Based on the Joint Utility of Efficacy and Toxicity | 2017-10-13 | Paper |
| https://portal.mardi4nfdi.de/entity/Q2829294 | 2016-10-27 | Paper |
| Prior effective sample size in conditionally independent hierarchical models | 2016-02-05 | Paper |
| Bayesian nonparametric estimation of targeted agent effects on biomarker change to predict clinical outcome | 2016-01-22 | Paper |
| Bayesian models and decision algorithms for complex early phase clinical trials | 2016-01-05 | Paper |
| A modified adaptive Lasso for identifying interactions in the Cox model with the heredity constraint | 2014-08-08 | Paper |
| Using Joint Utilities of the Times to Response and Toxicity to Adaptively Optimize Schedule–Dose Regimes | 2013-11-13 | Paper |
| Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer | 2013-04-22 | Paper |
| Rejoinder | 2013-04-22 | Paper |
| Optimizing the Concentration and Bolus of a Drug Delivered by Continuous Infusion | 2012-06-20 | Paper |
| A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity | 2012-03-05 | Paper |
| Dose-Finding Based on Feasibility and Toxicity in T-cell Infusion Trials | 2011-03-01 | Paper |
| Decision-Theoretic Designs for Pre-Phase II Screening Trials in Oncology | 2011-03-01 | Paper |
| Monitoring the Rates of Composite Events with Censored Data in Phase II Clinical Trials | 2011-03-01 | Paper |
| Adaptive Decision Making in a Lymphocyte Infusion Trial | 2011-03-01 | Paper |
| Seamlessly Expanding a Randomized Phase II Trial to Phase III | 2011-03-01 | Paper |
| Dose-Finding with Two Agents in Phase I Oncology Trials | 2011-03-01 | Paper |
| Utility-Based Optimization of Combination Therapy Using Ordinal Toxicity and Efficacy in Phase I/II Trials | 2010-08-03 | Paper |
| A review of phase 2-3 clinical trial designs | 2009-07-13 | Paper |
| Discussion on “A Hybrid Selection and Testing Procedure with Curtailment for Comparative Clinical Trials” by Elena M. Buzaianu and Pinyuen Chen | 2009-04-02 | Paper |
| Patient‐Specific Dose Finding Based on Bivariate Outcomes and Covariates | 2008-12-22 | Paper |
| Monitoring late-onset toxicities in phase I trials using predicted risks | 2008-09-25 | Paper |
| Determining the Effective Sample Size of a Parametric Prior | 2008-06-13 | Paper |
| Some geometric methods for constructing decision criteria based on two-dimensional parame\-ters | 2008-03-11 | Paper |
| Ethical issues in oncology biostatistics | 2007-11-02 | Paper |
| Dose-Finding Based on Efficacy-Toxicity Trade-Offs | 2007-06-11 | Paper |
| Dose-Finding Based on Multiple Toxicities in a Soft Tissue Sarcoma Trial | 2006-06-26 | Paper |
| A Geometric Approach to Comparing Treatments for Rapidly Fatal Diseases | 2006-06-20 | Paper |
| Determining a Maximum‐Tolerated Schedule of a Cytotoxic Agent | 2006-01-03 | Paper |
| Approximate Bayesian Evaluation of Multiple Treatment Effects | 2005-04-19 | Paper |
| Treatment Comparisons Based on Two‐Dimensional Safety and Efficacy Alternatives in Oncology Trials | 2005-04-13 | Paper |
| Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes | 2005-04-13 | Paper |
| A Strategy for Dose-Finding and Safety Monitoring Based on Efficacy and Adverse Outcomes in Phase I/II Clinical Trials | 2005-04-11 | Paper |
| Dose-Finding Based on Efficacy-Toxicity Trade-Offs | 2004-08-27 | Paper |
| Selecting Therapeutic Strategies Based on Efficacy and Death in Multicourse Clinical Trials | 2004-06-10 | Paper |
| Estimating Genomic Category Probabilities from Fluorescent in Situ Hybridization Counts with Misclassification | 1998-11-12 | Paper |
| Semiparametric Regression Analysis for Recurrent Event Interval Counts | 1997-01-01 | Paper |
| Practical Bayesian Guidelines for Phase IIB Clinical Trials | 1995-10-03 | Paper |
| Score tests in the two - way layout of counts | 1993-11-10 | Paper |
| Some Covariance Models for Longitudinal Count Data with Overdispersion | 1990-01-01 | Paper |
| Distribution-Free Confidence Intervals for a Parameter of Wilcoxon-Mann- Whitney Type for Ordered Categories and Progressive Censoring | 1989-01-01 | Paper |
| A Two-Stage Design for Choosing among Several Experimental Treatments and a Control in Clinical Trials | 1989-01-01 | Paper |
| Mixed Poisson Likelihood Regression Models for Longitudinal Interval Count Data | 1988-01-01 | Paper |
| Two-stage selection and testing designs for comparative clinical trials | 1988-01-01 | Paper |
| A theorem on regular infinitely divisible Cox processes | 1984-01-01 | Paper |
| A joint characterization of the multinomial distribution and the Poisson process | 1983-01-01 | Paper |
| Cluster shock models | 1981-01-01 | Paper |
| Huber-Sense Robust M-Estimation of a Scale Parameter, with Applications to the Exponential Distribution | 1979-01-01 | Paper |
| Count distributions, orderliness and invariance of Poisson cluster processes | 1979-01-01 | Paper |
| Random measures with aftereffects | 1978-01-01 | Paper |
| On the structure of regular infinitely divisible point processes | 1977-01-01 | Paper |
| https://portal.mardi4nfdi.de/entity/Q4191947 | 1977-01-01 | Paper |
